Examining the Psychedelic Renaissance
Season 2
A 15-week online event to explore, examine, and delve into the psychedelic Renaissance
Episode 10: Psychedelic-Assisted Psychotherapy for Eating Disorders and Cognitive Behavioural Therapies for PTSD + MDMA
November 24th, 5:00-6:30PM PST
Dr. Adele Lafrance
Psychologist & Research Scientist –
Novamind
Dr. Adele Lafrance
Psychedelic-Assisted Psychotherapy for Eating Disorders
Panel discussion with Dr. Reid Robison and Dr. Anne Wagner
November 24th, 5:00-6:30pm PST
Bio: Adele Lafrance, PhD, is a clinical psychologist, research scientist, and author. She is co-developer of Emotion-Focused Family Therapy. Adele is a leader in the research and practice of psychedelic medicine, with a focus on ayahuasca, MDMA, and psilocybin. She is the clinical investigator and strategy lead for the MAPS-sponsored MDMA-assisted psychotherapy study for eating disorders and a collaborator on the Imperial College study for psilocybin and anorexia nervosa. She is also co-developer of Emotion-Focused Ketamine-assisted Psychotherapy. Adele has a particular interest in mechanisms and models of healing, including spirituality, emotion processing, and couples and family therapy.
Webinar Topic: In this episode we will get to hear from some of the leading experts in the field of clinical psychedelic research. Both Dr. Adele Lafrance and Dr. Reid Robinson are currently focussed on a study looking at using MDMA to treat PTSD. While Dr. Anne Wagner also has a background investigating Eating Disorders, she will be touching on her work with MDMA + Cognitive Processing Therapy.
Recent Work:
“Psychedelic use and intimate partner violence: The role of emotion regulation” – Journal of Psychopharmacology
“Exploratory Research on Ayahuasca & Eating Disorder Recovery” – MAPS, Youtube
Can Psychedelic Drugs Heal? – American Psychological Association
Learn More
Dr. Reid Robison
Psychiatrist, Co-Founder – Cedar Psychiatry,
Medical Director
Dr. Reid Robison
Psychedelic-Assisted Psychotherapy for Eating Disorders
Pannel discussion with Dr. Adele Lafrance and Dr. Anne Wagner
November 24th, 5:00-6:30pm PST
Bio: Reid Robison, MD MBA, is a board-certified psychiatrist and co-founder at Cedar Psychiatry and serves as Medical Director of Center for Change, a leading Eating Disorder program. He is the co-developer of the Emotion-Focused Ketamine-assisted Psychotherapy model. Reid is currently the coordinating investigator for the MAPS-sponsored study MDMA assisted psychotherapy study of eating disorders. As an early adopter and researcher of Ketamine in psychiatry, Reid led a pivotal ketamine study leading up to the FDA-approval of Spravato. To date, Reid has guided thousands of ketamine therapy journeys and hundreds of Spravato dosing sessions and provides medical support and psychedelic therapy at plant medicine retreats abroad.
Webinar Topic: TBD
Recent Work:
Novamind Appoints Dr. Reid Robison as Chief Medical Officer – Psychedelic Finance
Psychedelics and Mental Health:Ketamine, MDMA, and Ayahuasca – Therapy Thoughts Podcast, Episode 31
Learn More
Dr. Anne Wagner
Psychologist, Founder – REMEDY
Dr. Anne Wagner
Psychedelic-Assisted Psychotherapy for Eating Disorders, and Cognitive Behavioral Therapies for PTSD + MDMA
Pannel discussion with Dr. Adele Lafrance and Dr. Reid Robison
November 24th, 5:00-6:30pm PST
Bio: Anne is one of the investigators of Cognitive-Behavioral Conjoint Therapy for PTSD + MDMA, a Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored trial. She will be leading the MAPS funded trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA. Anne has done extensive work with communities impacted by HIV, and collaborates on projects with LGBTQ and AIDS service organizations (ASOs) on trauma-informed care and trauma treatment. Anne trains and supervises students in evidence-based PTSD treatment and couples therapy, and provides consultation and training to other providers learning these treatments. Anne sits on the Quality Committee of Casey House, Toronto’s HIV/AIDS hospital, and is the past-Chair of the Traumatic Stress Section of the Canadian Psychological Association.
Academic Appointment – Adjunct Professor, Faculty of Arts, and Associate Member, Yeates School of Graduate Studies, Ryerson University
Fellowship – Canadian Institutes of Health Research, Ryerson University
Residency – Centre for Addiction and Mental Health, Toronto, Canada
Ph.D. – Clinical Psychology, Ryerson University
Webinar Topic: Anne will be joining Dr.Adele Lafrance and Dr. Reid Robinson to discuss studies that MAPS Canada is currently funding around psychedelic assisted psychotherapies and MDMA. Specifically, Anne will be sharing about her work with combining Cognitive Behavioural Therapies for PTSD with MDMA.
Recent Work:
From Ecstasy to Remedy – MDMA Therapy with Anne Wagner – Soul Space Podcast
Mental Health Innovation, PTSD, MDMA and More with Dr. Anne Wagner – SoundCloud
Learn More
Episode Summary: Hear from the MAPS Researchers. In this episode we will get to hear from some of the leading experts in the field of clinical psychedelic research. Both Dr. Adele Lafrance and Dr. Reid Robison are currently focussed on a study looking at using MDMA to treat PTSD. While Dr. Anne Wagner also has a background investigating Eating Disorders, she will be touching on her work with MDMA + Cognitive Processing Therapy.
Exclusive Post Webinar Sessions: (Exclusive Post-Webinar Session Details: Session take place in a private zoom room with the speaker and 6-10 other participants. Limited Capacity. Zoom links sent out the day of the event. 6:30-7:30PM PST, Tuesdays (following the speaker’s episode). Webinar attendance is not mandatory; however all passes include 1 complimentary ticket to the entire series! View all speaker post-webinar sessions here.)
- Join Adele and Reid for an Exclusive Q&A. Reid is currently the coordinating investigator for the MAPS-sponsored study MDMA assisted psychotherapy study of eating disorders, and Adele is the clinical investigator and strategy lead for the MAPS-sponsored MDMA-assisted psychotherapy study for eating disorders. This is your chance to meet with the two of them and have all of your questions answered in a semi-private session. To register, see Ep 10Ex: Exclusive w/ Adele & Reid.
- Join Anne for an Exclusive Q&A. Anne is one of the investigators of Cognitive-Behavioral Conjoint Therapy for PTSD + MDMA, a Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored trial. She will be leading the MAPS funded trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA. Anne has done extensive work with communities impacted by HIV, and collaborates on projects with LGBTQ and AIDS service organizations (ASOs) on trauma-informed care and trauma treatment. This is your chance to meet with her almost 1-1 and ask your questions regarding her studies or any of the other work she has done. To register, see Ep 10Ex: Exclusive w/ Anne.